NCT02043457Recruiting
Identification of Phenotypic Factors That Predict Success for Weight Loss and Long-term Weight Maintenance
Source: ClinicalTrials.gov · Last updated 13 Jul 2026
Brief summary (registry, in English)
The Investigational Weight Management Clinic now entitled the Weight Management Program at the University of Michigan was created to identify strategies that will result in cost-effective, long term weight management for overweight and obese individuals. The driving hypothesis of the clinic is that the 'one size fits all' philosophy is untenable with a complex disease such as obesity. The clinic will serve as a portal for patients to choose standard clinical care or to explore alternatives from a variety of clinical studies offered through the clinic. These studies will include further investigations into nutrition, the biological basis of weight and weight management and protocols using approved and experimental pharmaceuticals as well as technologies that aid in self-management of weight.
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 3200 (estimated)
- First submitted
- 17 Jan 2014
- Start date
- Aug 2009
- Primary completion date
- Dec 2030
- Lead sponsor
- University of Michigan
- Diseases
- Obesity
- NCT number
- NCT02043457
What you commit to
- Study type: Observational
- Planned participants: 3200
- From Aug 2009 to the primary completion date, Dec 2030
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Body weight fluctuation of more than 5 kg in the previous 3 months
- Prior bariatric surgery
Other illness
- Evidence of inherited disorders of lipid metabolism.
- History of Cancer within the last 5 years
- Human immunodeficiency virus (HIV) antibody positive.
- Uncontrolled thyroid disease
- Unstable angina or NY heart association class II failure or above
- Gastrointestinal disease specifically GI motility disorders
- Unstable neuropsychiatric disease including major depression/anxiety, eating disorder such as binge eating, bulimia or anorexia
- End stage renal or hepatic disease
- Autoimmune disorders (e.g. SLE)
- Any medical condition, which in the opinion of the investigator would make the patient unsuitable for recruitment, or could interfere with the patient participating in or completing the protocol.
Age
- Women of childbearing age must use a reliable form of contraception.
Other
- Patients with solid organ transplants.
- Participation in any other clinical trial within 90 days of entry into this trial.
- Pregnant or lactating females.
- A history or current alcohol/substance abuse and change in smoking habits or cessation in the past 6 months.
- Unwilling or unable to consent for the study.
Who the study is looking for
- Obese males and females: age \>20 years; Obese population defined as BMI \> or = 27 kg/m2
- Lean population BMI \< 27 but \> 17 kg/m2
- Able and willing to provide written informed consent for the trial
Age in the registry: 15 years to 75 years · Sex: All · Accepts healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| University of Michigan Coordinator of this site? Confirm its status | Ann Arbor | United States | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.